Articles with "long acting" as a keyword



Photo from wikipedia

Severe Hypoglycemia Risk With Long-Acting Insulin Analogs vs Neutral Protamine Hagedorn Insulin.

Sign Up to like & get
recommendations!
Published in 2021 at "JAMA internal medicine"

DOI: 10.1001/jamainternmed.2020.9176

Abstract: Importance Previous studies have found that the risk of severe hypoglycemia does not differ between long-acting insulin analogs and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes. However, these studies did not… read more here.

Keywords: insulin; risk; long acting; hypoglycemia ... See more keywords

Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.24163

Abstract: Key Points Question Are long-acting injectable antipsychotics (LAIAs) associated with a lower risk of disease relapse, health care use, and adverse events compared with oral antipsychotics among people in Hong Kong with schizophrenia? Findings In… read more here.

Keywords: oral antipsychotics; injectable antipsychotics; acting injectable; long acting ... See more keywords

Improving Outcomes in Schizophrenia-A Case for Initiation of Long-Acting Antipsychotics in Early-Phase Illness.

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA network open"

DOI: 10.1001/jamanetworkopen.2022.24172

Abstract: The reduction of adverse outcomes is of crucial importance in schizophrenia, a relapsing and remitting chronic illness with a 13- to 15-year reduction in life expectancy. 1 The recurrence of acute psychotic symptoms after a… read more here.

Keywords: illness; long acting; laia treatment; risk ... See more keywords

Immediate Postpartum Long-Acting Reversible Contraceptive Use Following State-Specific Changes in Hospital Medicaid Reimbursement

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.37918

Abstract: Key Points Question Are Medicaid policies that reimburse hospitals for immediate postpartum long-acting reversible contraception (LARC) associated with increased provision of this service? Findings In this cross-sectional study of more than 3 million births in… read more here.

Keywords: postpartum; immediate postpartum; postpartum long; acting reversible ... See more keywords

Long-Acting Reversible Contraception for Adolescents: A Review

Sign Up to like & get
recommendations!
Published in 2017 at "JAMA Pediatrics"

DOI: 10.1001/jamapediatrics.2017.0598

Abstract: Importance Adolescents have higher rates of unintended pregnancies than any other age group. Contraceptive implants and intrauterine devices (IUDs) are long-acting reversible contraceptives (LARCs) that are known to be highly effective in preventing pregnancy. New… read more here.

Keywords: reversible contraception; long acting; acting reversible; contraceptive ... See more keywords

Constructing a Metal–Organic Frameworks‐Based Long‐Acting Sequential Release System for the Treatment of Alzheimer's Disease

Sign Up to like & get
recommendations!
Published in 2024 at "Advanced Healthcare Materials"

DOI: 10.1002/adhm.202402425

Abstract: Due to the unclear pathogenesis of Alzheimer's disease (AD) and the lack of a completely cured medication, AD patients need to take medication in order and on time every day all one's life, which is… read more here.

Keywords: alzheimer disease; long acting; release; acting sequential ... See more keywords

Albumin Corona Overturns Long‐Acting Behaviors of Myristic Acid‐Conjugated Quetiapine Nanosuspension

Sign Up to like & get
recommendations!
Published in 2025 at "Advanced Healthcare Materials"

DOI: 10.1002/adhm.202500851

Abstract: This work aimed to investigate the interaction of a self‐assembled myristic acid‐conjugated quetiapine nanosuspension (QMN) with human serum albumin and its overturning effect on QMN's long‐acting performance. Albumin corona formation modified the physicochemical properties and… read more here.

Keywords: long acting; conjugated quetiapine; qmn; acid conjugated ... See more keywords

Discovery of a Potent, Long‐Acting, and CNS‐Active Inhibitor (BIA 10‐2474) of Fatty Acid Amide Hydrolase

Sign Up to like & get
recommendations!
Published in 2018 at "Chemmedchem"

DOI: 10.1002/cmdc.201800393

Abstract: Fatty acid amide hydrolase (FAAH) can be targeted for the treatment of pain associated with various medical conditions. Herein we report the design and synthesis of a novel series of heterocyclic‐N‐carboxamide FAAH inhibitors that have… read more here.

Keywords: acid amide; bia 2474; long acting; fatty acid ... See more keywords

Design of a Long‐Acting Morphine Prodrug for Safe Opioid Delivery

Sign Up to like & get
recommendations!
Published in 2025 at "ChemMedChem"

DOI: 10.1002/cmdc.202500499

Abstract: Effective opioid management in neonatal abstinence syndrome (NAS) and opioid use disorder (OUD) requires maintaining low, stable plasma opioid levels to prevent withdrawal without central side effects. Current treatments rely on frequent opioid dosing, such… read more here.

Keywords: morphine; design long; morphine prodrug; long acting ... See more keywords

Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone

Sign Up to like & get
recommendations!
Published in 2022 at "Clinical Pharmacology in Drug Development"

DOI: 10.1002/cpdd.1078

Abstract: TV‐46000 is a long‐acting subcutaneous antipsychotic that uses a novel copolymer drug delivery technology in combination with a well‐characterized molecule, risperidone, that is in clinical development as a treatment for schizophrenia. A population pharmacokinetic (PPK)… read more here.

Keywords: 46000 long; development; population pharmacokinetic; modeling simulation ... See more keywords

A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV

Sign Up to like & get
recommendations!
Published in 2025 at "Clinical Pharmacology in Drug Development"

DOI: 10.1002/cpdd.1538

Abstract: Long‐acting (LA) cabotegravir 200‐mg/mL (CAB200) injections are approved for HIV‐1 prevention and as a complete LA HIV‐1 treatment regimen with rilpivirine. A high‐concentration suspension formulation, cabotegravir 400 mg/mL (CAB400‐D), was developed to enable less frequent… read more here.

Keywords: long acting; hiv; cab400; cabotegravir ... See more keywords